Zuga Matt
SEC insider (Form 3/4/5 filer). CIK 0001790214. CFO & Chief Business Officer at Acumen Pharmaceuticals, Inc. (ABOS) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Jan 22, 2026. Located in NEWTON, MA.
Companies Zuga Matt has filed insider reports for
- Acumen Pharmaceuticals, Inc. (ABOS): Officer, CFO & Chief Business Officer
- ELUTIA INC. (ELUT): Director, 10% Owner
Zuga Matt
CIK: 0001790214
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jan 22, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect1.7K shares at avg. $1.86$3K - Jan 21, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect2.5K shares at avg. $1.81$4K - Jan 16, 2026ABOS
Acumen Pharmaceuticals, Inc.
AwardDirect99.1K shares- - Jan 8, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect6.9K shares at avg. $1.82$13K - Jan 7, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect4.1K shares at avg. $2.00$8K - Jan 7, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect1.7K shares at avg. $1.99$3K - Jan 6, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect5.1K shares at avg. $1.97$10K - Jan 5, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect4K shares at avg. $1.96$8K - May 29, 2025ELUT
ELUTIA INC.
AwardDirectStock Option (Right to Buy)
60.3K shares- - Jan 23, 2025ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect28.9K shares at avg. $1.72$50K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 22, 2026 |  ABOS Acumen Pharmaceuticals, Inc. | Sale | 1,687 | $1.86 | $3,138 | Direct |
| Jan 21, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Sale | 2,473 | $1.81 | $4,469 | Direct |
| Jan 16, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Award | 99,133 | - | $0 | Direct |
| Jan 8, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Sale | 6,888 | $1.82 | $12,513 | Direct |
| Jan 7, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Sale | 4,105 | $2.00 | $8,189 | Direct |
| Jan 7, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Sale | 1,700 | $1.99 | $3,377 | Direct |
| Jan 6, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Sale | 5,100 | $1.97 | $10,028 | Direct |
| Jan 5, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Sale | 4,000 | $1.96 | $7,842 | Direct |
| May 29, 2025 |  ELUT ELUTIA INC. | Award Stock Option (Right to Buy) | 60,339 | - | - | Direct |
| Jan 23, 2025 | ABOS Acumen Pharmaceuticals, Inc. | Sale | 28,902 | $1.72 | $49,633 | Direct |
1-10 of 13 transactions